Cytochrome P450 Genotyping for Pain Management Medications
Date: Thursday, July 05, 2012
Author: McClure, F. Leland, MSci, PhD
Director, Pain Management
Quest Diagnostics
St. Louis, MO
Description: Leland McClure, MSci, PhD, discusses how variations in DNA coding of the cytochrome P450 family of enzymes can affect the rate and extent of drug metabolism and influence a patient's response to pain management medications – critical information for healthcare providers prescribing opioids to their patients for pain management.
Learning objectives - at the conclusion of this program participants will be able to:
• Discuss how variations in DNA coding of the cytochrome P450 family of enzymes can affect the rate and extent of drug metabolism
• Describe how genetic differences may influence a patient's response to pain management medications
• Communicate how cytochrome P450 test results may help physicians to develop a treatment strategy for patients using pain management medications
• Conclude how and when to use cytochrome P450 test for pain management
Related Content
Presentation:
Urine Drug Testing for Patients With Chronic Pain
McCarberg, Bill, MD
Presentation:
Clinical Aspects of Risk Management in Prescribing Opioids
Passik, Steven D. , PhD
Expert Insight:
Pain Medication - The Role of Genetic Variation in Drug Metabolism
McClure, F. Leland, MSci, PhD